In partnership with the Wellcome Trust, the Milken Institute's FasterCures and Financial Innovations Lab are examining ways to leverage innovative finance solutions to support the development and commercialization of new antibiotics. Government and philanthropy have led the way in funding important early-stage research in antibiotics, but their leadership alone will not be enough to create a sustainable and resilient antibiotics market. During this session, we will discuss the potential for specific innovative financing approaches to drive investment in the antibiotics market and the steps that need to be taken to implement them.